DOP53 Pregnancy outcomes in the ozanimod clinical development program in relapsing multiple sclerosis, Ulcerative Colitis, and Crohn’s Disease - Dubinsky, MC; Mahadevan, U; Charles, L (J Crohns Colitis, 2021)
et al.